Treatment of HIV-1 infection in combination with other antiretroviral agents
Contraindications:
Hypersensitivity to abacavir or lamivudineKnown HLA-B*5701 positive patients (risk of severe hypersensitivity to abacavir)Severe hepatic impairment (use with caution)Patients with lactic acidosis or severe hepatomegaly with steatosis
Side Effects:
Common Side EffectsAbacavir-related:Hypersensitivity reaction (fever, rash, gastrointestinal symptoms, respiratory symptoms) — can be life-threateningLamivudine-related:Headache, nausea, fatigueMild gastrointestinal discomfort (diarrhea, abdominal pain)General: Sleep disturbances, dizziness, myalgia⚠️ Serious / Life-Threatening Side EffectsAbacavir hypersensitivity reaction — can be fatal if therapy continuedLactic acidosis / hepatic steatosis (rare but serious)Severe hepatotoxicityExacerbation of hepatitis B in co-infected patients if lamivudine is discontinued
Precautions:
HLA-B*5701 screening before starting abacavir to prevent hypersensitivity reaction.Monitor liver function tests regularly.Do not restart abacavir after hypersensitivity reaction, even if symptoms improve.Caution in renal impairment (lamivudine is renally excreted) — dose adjustment may be required.Pregnancy: Can be used if benefits outweigh risks; monitor maternal and fetal health.Do not stop therapy abruptly — may cause viral rebound or resistance.Avoid over-the-counter medications without consultation — check for drug interactions.
Dietary Restrictions:
Can be taken with or without food.No strict dietary restrictions, but maintain a healthy, balanced diet to support immune health.Avoid alcohol and recreational drugs that may strain the liver.Maintain adequate hydration.Avoid herbal supplements that interact with liver metabolism or antiretrovirals (e.g., St. John’s Wort).
You’re now part of a safe, inclusive space for health and wellness. We’ll keep you updated with useful resources, new services, and exclusive support options.